EPIC – Efficient Treatment of Pharmaceutical Residue at Source

Leading organisations:
Finnish Environment Institute (SYKE)

Timeframe:
2016-2019

Geographic Area:
Scandinavia

Objectives:

-Identify the APIs entering the waste water stream at different sources and testing cost-effective technological solutions to treat APIs at their primary emission sources.
-The different technologies will be tested in pilot studies.
-Seek pollution prevention instruments in collaboration with key stakeholders.


Target audience:
Environmental experts, General Public, Hospitals, Hospitals/health system stakeholders, National/Local decision and policy makers, Pharmaceutical manufacturers, Pharmacists, Scientists, Waste/water treatment providers, and Water/waste service providers

Area of interest:
Emergence of anti-microbial resistance (AMR), Occurrence of pharmaceuticals in the environment, Wastewater, and Water treatment technologies

Activities:

Work packages:

1) Identification of pharmaceutical residue emission loads and risk

2) Pilot testing of wastewater technologies in real conditions

3) Cost-effectiveness of wastewater treatment solutions for bioaccumulative and persistent pharmaceutical residues

4) Policy Recommendations for sustainable management of pharmaceuticals

5) Coordination and Communication


Communication material:

Return to search form.

HCWH Europe gratefully acknowledges the financial support of the European Commission (EC)’s LIFE+ programme, the Federal Ministry for the Environment, Nature Conservation, and Nuclear Safety (BMU) Germany, and the German Environment Agency (UBA). HCWH Europe is solely responsible for the content of this project and related materials. The views expressed do not reflect the official views of the EC, BMU, or UBA.